FTC orders Illumina to divest $7.1 billion acquisition of cancer test developer Grail
Lilly says experimental Alzheimer's drug reduces amyloid in small study
BioNTech, DualityBio to develop cancer treatment drugs in over $1.5-bln deal
Seagen's Padcev eyes FDA approval
*please scroll down for all the latest news*
